Belinda T. Doyle-Olsen

Belinda T. Doyle-Olsen is a seasoned professional in the pharmaceutical industry, currently serving as Senior Director and Head of Global Medical Writing at Ferring Pharmaceuticals since April 2020. With extensive experience at Ferring Pharmaceuticals from 2007 to 2018 in various roles such as Global Clinical Project Leader in Urology, Belinda has demonstrated expertise in developing Clinical Development Plans, managing clinical trials, and providing strategic input for regulatory strategies. Prior to this, Belinda founded AddMe Consulting ApS and worked as a Senior International Clinical Trial Manager and Clinical Team Leader, enhancing trial designs and stakeholder communication. Earlier career experiences include a Pharmacovigilance Officer at Actavis A/S and a Postdoctoral Research Fellow at St. Jude Children's Research Hospital, focusing on colorectal cancer research. Belinda holds a Ph.D. in Biochemistry from University College Dublin and a Bachelor of Science (Hons) in Biochemistry from the University of Galway.